We gratefully acknowledge support from
the Simons Foundation and member institutions.

Quantitative Methods

New submissions

[ total of 4 entries: 1-4 ]
[ showing up to 2000 entries per page: fewer | more ]

New submissions for Fri, 4 Dec 20

[1]  arXiv:2012.01981 [pdf, other]
Title: MoleculeKit: Machine Learning Methods for Molecular Property Prediction and Drug Discovery
Comments: Supplementary Material: this https URL
Subjects: Quantitative Methods (q-bio.QM); Machine Learning (cs.LG)

Properties of molecules are indicative of their functions and thus are useful in many applications. As a cost-effective alternative to experimental approaches, computational methods for predicting molecular properties are gaining increasing momentum and success. However, there lacks a comprehensive collection of tools and methods for this task currently. Here we develop the MoleculeKit, a suite of comprehensive machine learning tools spanning different computational models and molecular representations for molecular property prediction and drug discovery. Specifically, MoleculeKit represents molecules as both graphs and sequences. Built on these representations, MoleculeKit includes both deep learning and traditional machine learning methods for graph and sequence data. Noticeably, we propose and develop novel deep models for learning from molecular graphs and sequences. Therefore, MoleculeKit not only serves as a comprehensive tool, but also contributes towards developing novel and advanced graph and sequence learning methodologies. Results on both online and offline antibiotics discovery and molecular property prediction tasks show that MoleculeKit achieves consistent improvements over prior methods.

Cross-lists for Fri, 4 Dec 20

[2]  arXiv:2012.02101 (cross-list from stat.AP) [pdf, other]
Title: The Statistics of Noisy One-Stage Group Testing in Outbreaks
Comments: 30 pages, 20 figures
Subjects: Applications (stat.AP); Discrete Mathematics (cs.DM); Quantitative Methods (q-bio.QM)

In one-stage or non-adaptive group testing, instead of testing every sample unit individually, they are split, bundled in pools, and simultaneously tested. The results are then decoded to infer the states of the individual items. This combines advantages of adaptive pooled testing, i. e. saving resources and higher throughput, with those of individual testing, e. g. short detection time and lean laboratory organisation, and might be suitable for screening during outbreaks. We study the COMP and NCOMP decoding algorithms for non-adaptive pooling strategies based on maximally disjunct pooling matrices with constant row and column sums in the linear prevalence regime and in the presence of noisy measurements motivated by PCR tests. We calculate sensitivity, specificity, the probabilities of Type I and II errors, and the expected number of items with a positive result as well as the expected number of false positives and false negatives. We further provide estimates on the variance of the number of positive and false positive results. We conduct a thorough discussion of the calculations and bounds derived. Altogether, the article provides blueprints for screening strategies and tools to help decision makers to appropriately tune them in an outbreak.

[3]  arXiv:2012.02113 (cross-list from q-bio.PE) [pdf, other]
Title: Entropy and Diversity: The Axiomatic Approach
Authors: Tom Leinster
Comments: Book, viii + 442 pages, to be published by Cambridge University Press in April 2021
Subjects: Populations and Evolution (q-bio.PE); Information Theory (cs.IT); Classical Analysis and ODEs (math.CA); Category Theory (math.CT); Quantitative Methods (q-bio.QM)

This book brings new mathematical rigour to the ongoing vigorous debate on how to quantify biological diversity. The question "what is diversity?" has surprising mathematical depth, and breadth too: this book involves parts of mathematics ranging from information theory, functional equations and probability theory to category theory, geometric measure theory and number theory. It applies the power of the axiomatic method to a biological problem of pressing concern, but the new concepts and theorems are also motivated from a purely mathematical perspective.
The main narrative thread requires no more than an undergraduate course in analysis. No familiarity with entropy or diversity is assumed.

[4]  arXiv:2012.02151 (cross-list from cs.LG) [pdf, other]
Title: Dr-COVID: Graph Neural Networks for SARS-CoV-2 Drug Repurposing
Subjects: Machine Learning (cs.LG); Molecular Networks (q-bio.MN); Quantitative Methods (q-bio.QM)

The 2019 novel coronavirus (SARS-CoV-2) pandemic has resulted in more than a million deaths, high morbidities, and economic distress worldwide. There is an urgent need to identify medications that would treat and prevent novel diseases like the 2019 coronavirus disease (COVID-19). Drug repurposing is a promising strategy to discover new medical indications of the existing approved drugs due to several advantages in terms of the costs, safety factors, and quick results compared to new drug design and discovery. In this work, we explore computational data-driven methods for drug repurposing and propose a dedicated graph neural network (GNN) based drug repurposing model, called Dr-COVID. Although we analyze the predicted drugs in detail for COVID-19, the model is generic and can be used for any novel diseases. We construct a four-layered heterogeneous graph to model the complex interactions between drugs, diseases, genes, and anatomies. We pose drug repurposing as a link prediction problem. Specifically, we design an encoder based on the scalable inceptive graph neural network (SIGN) to generate embeddings for all the nodes in the four-layered graph and propose a quadratic norm scorer as a decoder to predict treatment for a disease. We provide a detailed analysis of the 150 potential drugs (such as Dexamethasone, Ivermectin) predicted by Dr-COVID for COVID-19 from different pharmacological classes (e.g., corticosteroids, antivirals, antiparasitic). Out of these 150 drugs, 46 drugs are currently in clinical trials. Dr-COVID is evaluated in terms of its prediction performance and its ability to rank the known treatment drugs for diseases as high as possible. For a majority of the diseases, Dr-COVID ranks the actual treatment drug in the top 15.

[ total of 4 entries: 1-4 ]
[ showing up to 2000 entries per page: fewer | more ]

Disable MathJax (What is MathJax?)

Links to: arXiv, form interface, find, q-bio, recent, 2012, contact, help  (Access key information)